Lanean...
Gene editing and gene-based therapeutics for cardiomyopathies
With an increasing understanding of genetic defects leading to cardiomyopathy, focus is shifting to methods for correcting these underlying genetic defects. One approach involves treating mutant RNA through antisense oligonucleotides, and the first drug has now received regulatory approval to treat...
Gorde:
| Argitaratua izan da: | Heart Fail Clin |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849064/ https://ncbi.nlm.nih.gov/pubmed/29525646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hfc.2017.12.006 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|